✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals

Agilus Diagnostics Ltd.

None

Market Cap
₹0 Cr.
P/E
0.00

Agilus Diagnostics Ltd.

Insufficient data

FAQs on Agilus Diagnostics Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Agilus Diagnostics is 0

View FAQ's On Business
Growth Table
  • Agilus Diagnostics Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Balance Sheet
  • Agilus Diagnostics Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Agilus Diagnostics Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Cash Flow
  • Agilus Diagnostics Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Agilus Diagnostics Ltd.
  • Jagsonpal Pharma
  • Hamps Bio
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Agilus Diagnostics Ltd. Financials

Agilus Diagnostics balance sheet is weak and might have solvency issues

Yes, The debt of Agilus Diagnostics is increasing.
Latest debt of Agilus Diagnostics is -₹529.06 Crs as of Mar-24.
This is greater than Mar-23 when it was -₹643.55 Crs.

No, profit is decreasing.
The profit of Agilus Diagnostics is ₹66.58 Crs for Mar 2024, ₹117 Crs for Mar 2023 and ₹555 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Agilus Diagnostics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech